Intuitive Surgical Surpasses Quarterly Expectations Due to High Demand for Surgical Robots

• Da Vinci procedure volume globally increased 16% year-over-year in Q1, with 2026 growth outlook raised to 13.5%-15.5% from the prior 13%-15% range
• Adjusted earnings per share came in at $2.50, beating analyst expectations on revenue that surpassed estimates by $150 million
• The company increased its 2026 adjusted gross profit margin projection to 67.5%-68.5% from 67%-68%, factoring in a 1% revenue impact from tariffs

Summary: Intuitive Surgical Beats Q1 Expectations on Strong Robot Demand

Key Financial Results:

Intuitive Surgical exceeded Wall Street estimates for Q1, reporting adjusted earnings of $2.50 per share and revenue of $2.77 billion, surpassing analyst expectations of $2.62 billion. The company announced these results on April 21.

Main Drivers:

The medical device maker's performance was fueled by robust demand for its da Vinci surgical robots, used in minimally invasive procedures including weight-loss, kidney, and gastric bypass surgeries. Global da Vinci procedure volumes increased 16% year-over-year in Q1.

Updated Guidance:

Intuitive raised its 2026 outlook, now projecting:

• Worldwide da Vinci procedure growth of 13.5% to 15.5% (up from 13% to 15% previously)
• Adjusted gross profit margin of 67.5% to 68.5% of revenue (up from 67% to 68%)
• Estimated 1% revenue impact from tariffs incorporated into guidance

Market Position:

Intuitive maintains dominance in surgical robotics, though it faces new competition from Medtronic's Hugo robot, which received FDA clearance in late 2025. The approval represents the first significant competitor in robotic-assisted surgery for Intuitive.

Market Implications:

The strong results and raised guidance reflect sustained hospital investment in advanced surgical technology as healthcare facilities address procedure backlogs and expand minimally invasive care access. The company's ability to beat estimates despite emerging competition demonstrates its entrenched market position and the growing adoption of robotic surgery platforms.